Nuvation Bio (NUVB) Return on Sales [ROS] (2024 - 2026)
Nuvation Bio (NUVB) recorded Return on Sales [ROS] of -161.06% in Q2 2026, up 1154.66 percentage points from -1315.73% a year earlier but down 165.73 percentage points from the prior quarter.
Powered by 
Analysis
Nuvation Bio (NUVB) Return on Sales [ROS] (2024 - 2026) Analysis & Trends
On a TTM basis, Nuvation Bio's Return on Sales [ROS] came in at -81.00% as of Jun 30, 2026, up 1483.86 percentage points year-over-year; for FY2025, it came in at -338.72%, up 7188.61 percentage points from FY2024.
- Across earlier years, Return on Sales [ROS] came in at -7527.33% in FY2024.
- Quarterly Return on Sales [ROS] has ranged from -32779.44% in Q2 2024 to 4.66% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has increased for five consecutive quarters, with an average year-over-year change of +8317.15 percentage points over the last five quarters.
- Per Business Quant, the preceding three quarters came in at 4.66% (Q1 2026), -81.30% (Q4 2025) and -430.14% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Nuvation Bio | 1.46 Bn | -931.95 Mn | 42.84 Mn | -93.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -93.90% |
| Jun 30, 2026 | -161.06% |
| Mar 31, 2026 | 4.66% |
| Dec 31, 2025 | -81.30% |
| Sep 30, 2025 | -430.14% |
| Jun 30, 2025 | -1,315.73% |
| Mar 31, 2025 | -1,913.23% |
| Dec 31, 2024 | -944.53% |
| Sep 30, 2024 | -6,616.37% |
| Jun 30, 2024 | -32,779.44% |
API Access
Nuvation Bio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NUVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NUVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NUVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();